Tonix Promotes Thomas Englese to Chief Commercial Officer
Tonix Pharmaceuticals has promoted Thomas Englese to Chief Commercial Officer following his instrumental role in the U.S. launch of TONMYA. The management change reflects the company's continued commercial focus on its fibromyalgia and migraine treatments.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day